Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) FCF Margin (2016 - 2025)

Palisade Bio (PALI) has disclosed FCF Margin for 14 consecutive years, with 71060.0% as the latest value for Q3 2025.

  • On a quarterly basis, FCF Margin changed N/A to 71060.0% in Q3 2025 year-over-year; TTM through Sep 2025 was 126050.0%, a N/A change, with the full-year FY2023 number at 4454.8%, changed N/A from a year prior.
  • FCF Margin was 71060.0% for Q3 2025 at Palisade Bio, down from 90850.0% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 233300.0% in Q1 2025 to a low of 1410.4% in Q1 2023.
  • A 3-year average of 78774.53% and a median of 71060.0% in 2025 define the central range for FCF Margin.
  • Biggest YoY gain for FCF Margin was 2794065bps in 2021; the steepest drop was 2794065bps in 2021.
  • Palisade Bio's FCF Margin stood at 73.06% in 2021, then plummeted by -2031bps to 1410.4% in 2023, then skyrocketed by 5138bps to 71060.0% in 2025.
  • Per Business Quant, the three most recent readings for PALI's FCF Margin are 71060.0% (Q3 2025), 90850.0% (Q2 2025), and 233300.0% (Q1 2025).